Clinical Trial Update: Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing results for Adefovir Dipivoxil in compensated chronic hepatitis B, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Chronic Hepatitis B | Phase 3 | Status: COMPLETED | Results posted: 2009-08-03